glp-1 nad and GLP-1: What the Research Actually Shows GLP-1 Supplement for Weight Management

WeightWatchers has conducted a 6-month clinical trial of 180 participants on GLP-1 medication (Heinberg et al.), but the manuscript is under review and has not yet been published in a peer-reviewed journal

In a public advisory on Wednesday, Health Canada said that as interest grows in GLP-1 products for weight loss, "some people may turn to unauthorized or counterfeit products, which could pose serious health risks because they have not been assessed by Health Canada for safety, effectiveness, or quality." The versions of the medications authorized for use in Canada are semaglutide (Ozempic and Wegovy injections and Rybelsus oral tablets) and tirzepatide (Mounjaro and Zepbound injections)

Liraglutide, in particular, has a half-life of only around 13 hours and requires a daily injection

Exenatide once weekly versus placebo in Parkinsons disease: A randomised, double-blind, placebo-controlled trial

With TrimRx, clients never feel like just another number

Macconell L, Pencek R, Li Y, Maggs D, Porter L